Vinorelbine Suppliers & Bulk Manufacturers
Available Forms: Intravenous Injection, Oral Capsule
Available Strengths: Injection: 10 mg/mL; Capsule : 20 mg, 30 mg, 40 mg
Reference Brands: Navelbine® , Alocrest (US & EU)
Category:
Oncology Cancer Care
Vinorelbine (brand Navelbine®) is a chemotherapy drug used for non-small cell lung cancer and advanced breast cancer. Available as IV injection (10 mg/mL) and oral capsules (20 mg, 30 mg, 40 mg), it disrupts microtubule formation to stop cancer cell division. Sourced by GMP-compliant B2B suppliers, it is widely available in the US and EU for reliable oncology treatment.
Vinorelbine is available in Intravenous Injection, Oral Capsule
and strengths such as Injection: 10 mg/mL; Capsule : 20 mg, 30 mg, 40 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Vinorelbine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Vinorelbine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Vinorelbine, marketed as Navelbine®, is an essential chemotherapy agent used for the treatment of non-small cell lung cancer (NSCLC) and advanced breast cancer. Available as an intravenous injection and oral capsules, with strengths like 10 mg/mL (IV) and 20 mg, 30 mg, and 40 mg (oral), Vinorelbine inhibits cell division by disrupting microtubule formation. Widely sourced by B2B pharmaceutical suppliers, Vinorelbine is available globally, including in the US and EU. Manufactured under GMP standards, it provides reliable therapy options for hospitals and oncology centers fighting aggressive cancers.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing